Commissioners approve Dupont grant application
The application, commissioners said, is related to projects in the village of Dupont that are unrelated to damage from the April 2 tornado. Dupont Mayor Robert Heidenescher said that the village has applied unsuccessfully for funds before, but the hope is that the village will be able to fund three community improvement projects if the money is allocated.
"Number one is to build a new community center," he said during a phone interview. "Number two is we're going to do improvements at the little league ball diamond, and the third project is a canoe launch down along the Auglaize River."
Commissioners also passed measures allocating Community Development Block Grant and revolving loan fund money totaling $140,000 to the Putnam County Historical Museum in Kalida to fund the construction and installation of Americans with Disabilities Act-compliant improvements, including a wheelchair ramp.
Featured Local Savings
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Altasciences Chosen by Steel Therapeutics to Support the Launch of Pivotal Toxicology Study for Fizurex™
LAVAL, Québec--(BUSINESS WIRE)-- Altasciences is pleased to have been chosen by Steel Therapeutics, Inc. ('Steel'), to initiate a pivotal toxicology study for Fizurex™, a novel topical therapy for the treatment of anal fissures. The GLP-compliant study is currently being conducted at Altasciences' preclinical facility in Columbia, MO. It marks a key milestone in Steel's regulatory development, as the company prepares for an Investigational New Drug (IND) application in early 2026. The GLP-compliant study is currently being conducted at Altasciences' preclinical facility in Columbia, MO. It marks a key milestone in Steel's regulatory development, as the company prepares for an Investigational New Drug (IND) application in early 2026. 'We're proud to be supporting Steel Therapeutics at this key stage of their development journey,' said Steve Mason, Co-COO at Altasciences. 'Our teams are aligned in their commitment to accelerate the delivery of patient-centered therapies. The initiation of this study is another example of how early collaboration and scientific rigor can bring important treatments closer to market.' Fizurex™, a patent-pending compounded wipe, has seen widespread use in clinical practice and is now progressing through the formal regulatory pathway to reach broader patient populations under FDA oversight. Steel engaged Altasciences due to their deep expertise in preclinical safety evaluation and proven ability to execute with speed and precision. 'Working with Altasciences allows us to maintain the highest standards of quality as we move Fizurex™ into its next phase of development,' said Matt Stahl, CEO and Founder of Steel Therapeutics. 'This study represents a major step forward for our company and for the patients who stand to benefit from more consistent, scalable access to this treatment.' Altasciences' integrated, collaborative approach to drug development enables companies like Steel to move efficiently from discovery through to clinical trials, all under one organizational umbrella. 'We look forward to continuing our partnership with Steel Therapeutics as they advance their portfolio of innovative, patient-focused therapies,' added Mason. About Altasciences Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 30 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences' integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, research support, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster. To learn more about Altasciences, visit Steel Therapeutics' mission is to improve the lives of patients by scaling access to compounded drugs that have a proven track record of safety and effectiveness. With a team of pharmacist-founders who have built and operated retail compounding programs, Steel is well-positioned to identify both high-impact drug candidates and innovative delivery systems. Steel has selected a novel treatment for anal fissures as its product entry point. The company's Fizurex™ wipe utilizes a combination therapy that is commonly compounded by pharmacists and incorporates it into a single-use wipe. By bringing rigorous safety and efficacy testing, Current Good Manufacturing Practices (CGMP), and a patient-friendly format to this drug combination, Steel believes it can dramatically improve outcomes for patients.
Business Wire
4 hours ago
- Business Wire
3Play Media Reintroduces Itself as Global Video Solutions Leader Backed by 15+ Years of AI Innovation
BOSTON--(BUSINESS WIRE)-- 3Play Media today announced a comprehensive rebrand reflecting its transformation from a video accessibility tech company into a leader in video localization and global accessibility solutions, driven by breakthrough AI technology that delivers unprecedented quality control and customization. "Our expansion represents more than adding language capabilities—it's about reimagining how organizations reach global audiences while maintaining the highest accessibility and quality standards." Josh Miller, co-CEO, 3Play Media Founded in 2008 out of MIT, 3Play Media was one of the first captioning companies to utilize AI, combining automated speech recognition (ASR) with custom modeling, patented software tools, and human review to deliver faster, more affordable video accessibility solutions to millions of people. With over 15 years of experience honing AI models for speech tech, 3Play Media is now applying their learnings to audio description, dubbing, and subtitling, where AI technology has only recently caught up. "Our expansion represents more than adding language capabilities—it's about reimagining how organizations reach global audiences while maintaining the highest accessibility and quality standards," said Josh Miller, Co-CEO and Co-Founder of 3Play Media. 'By leveraging advances in speech-to-text, text-to-speech, and computer vision, we've unlocked more efficient and cost-effective ways to deliver inclusive video experiences at scale.' Unlike competitors offering either AI-only or traditional human solutions, 3Play Media offers fully customizable, hybrid workflows that enable customers to choose the precise blend of AI and human review that best aligns with their goals. Whether that's premium AI, a light cleanup to remove hallucinations and other basic AI pitfalls, full review to deliver compliance with major accessibility laws like the Americans with Disabilities Act (ADA) and European Accessibility Act (EAA), or comprehensive expert review for premium streaming content, 3Play Media gives organizations the flexibility to meet their quality, budget, turnaround, and brand needs. "What makes 3Play unique is our ability to give customers complete control of the range of options between AI only and comprehensive expert review," said Chris Antunes, Co-CEO and Co-Founder of 3Play Media. "We believe the future lies in intelligently combining AI and human expertise to give customers unparalleled brand and budget safety." The refreshed brand positions 3Play as a technology-forward leader with a sharper, more contemporary design that reflects their evolution to a global, AI-enabled video accessibility and localization platform. "Our new brand identity communicates both technical sophistication and a deep understanding of global content needs," said Lily Bond, Chief Growth Officer. "It positions us alongside leading technology companies while reinforcing the trust and reliability 3Play customers expect." 3Play Media's solutions integrate seamlessly with existing workflows through 40+ platform integrations and custom API solutions, serving clients from major broadcasters and streaming platforms to educational institutions worldwide. About 3Play Media 3Play Media is a leading provider of video accessibility and localization solutions, blending proprietary tooling, advanced AI technology, and human expertise to deliver high-quality services at scale. Headquartered in Boston, the company serves organizations worldwide with its dubbing, subtitling, captioning, and audio description services—making inclusive, multilingual video content seamless.
Yahoo
5 hours ago
- Yahoo
Red Cat's (RCAT) Teal Drones Secures Prestigious AS9100 Certification
Red Cat Holdings, Inc. (NASDAQ:RCAT) ranks among the . Red Cat Holdings, Inc. (NASDAQ:RCAT) announced on August 13 that Teal Drones, a subsidiary, obtained AS9100 certification from NSF International Strategic Registrations in July 2025. The AS9100 standard is the internationally accepted standard for quality control in the space, defense, and aviation industries. The certification encompasses the entire product lifespan, including design, production, and maintenance procedures. Alexey Yuzhakov/ The certification confirms that Teal Drones' Black Widow drone, the winner of the U.S. Army's Short-Range Reconnaissance Program, has quality management procedures in place. The Black Widow is intended for military use as a secure, NDAA-compliant drone for intelligence, surveillance, and reconnaissance. Red Cat Holdings, Inc. (NASDAQ:RCAT) is a Puerto Rico-based company that supplies the drone sector with products, services, and solutions. The company offers its services to the consumer, military, and consumer sectors. While we acknowledge the potential of RCAT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RCAT and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
